<?xml version="1.0" encoding="UTF-8"?>
<p id="p0135">As of June 29, 2020, an assessment of clinical trials for COVID-19 emerging therapies on ClinicalTrials.gov produced 1154 search results. The number and type of trials of the therapies included in this review are summarized in 
 <xref rid="tbl2" ref-type="table">Table 2</xref> . Emerging trials of note include the use of low-dose radiation therapy to suppress the cytokine storm and resultant pulmonary inflammation and edema
 <xref rid="bib118" ref-type="bibr">
  <sup>118</sup>
 </xref> as well as evaluation of ivermectin based on its in vitro anti–SARS-CoV-2 effects.
 <xref rid="bib119" ref-type="bibr">
  <sup>119</sup>
 </xref>
</p>
